Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples